AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Satralizumab in South Africa
1 product registered with SAHPRA — 0 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ENSPRYNG | 55/30.1/0627 | Roche Products (Pty) Ltd | suspended | 9 Jul 2025 |
Satralizumab — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Satralizumab, of which 0 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Satralizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.